AAAAAA

   
Results: 1-20 |
Results: 20

Authors: Gaglia, JL Harlan, DM
Citation: Jl. Gaglia et Dm. Harlan, Transplantation tolerance, CURR DIR AU, 4, 2001, pp. 283-307

Authors: Kirk, AD Blair, PJ Tadaki, DK Xu, H Harlan, DM
Citation: Ad. Kirk et al., The role of CD154 in organ transplant rejection and acceptance, PHI T ROY B, 356(1409), 2001, pp. 691-702

Authors: Elster, EA Xu, H Tadaki, DK Burkly, LC Berning, JD Baumgartner, RE Cruzata, F Patterson, NB Harlan, DM Kirk, AD
Citation: Ea. Elster et al., Primate skin allotransplantation with anti-CD154 monotherapy, TRANSPLAN P, 33(1-2), 2001, pp. 675-676

Authors: Elster, EA Xu, H Tadaki, DK Montgomery, S Burkly, LC Berning, JD Baumgartner, RE Cruzata, F Marx, R Harlan, DM Kirk, AD
Citation: Ea. Elster et al., Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates, TRANSPLANT, 72(9), 2001, pp. 1473-1478

Authors: Hoffmann, SC Stanley, EM Cox, ED Craighead, N DiMercurio, BS Koziol, DE Harlan, DM Kirk, AD Blair, PJ
Citation: Sc. Hoffmann et al., Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes, TRANSPLANT, 72(8), 2001, pp. 1444-1450

Authors: Cox, ED Hoffmann, SC DiMercurio, BS Wesley, RA Harlan, DM Kirk, AD Blair, PJ
Citation: Ed. Cox et al., Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6, TRANSPLANT, 72(4), 2001, pp. 720-726

Authors: Kirk, AD Tadaki, DK Celniker, A Batty, DS Berning, JD Colonna, JO Cruzata, F Elster, EA Gray, GS Kampen, RL Patterson, NB Szklut, P Swanson, J Xu, H Harlan, DM
Citation: Ad. Kirk et al., Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates, TRANSPLANT, 72(3), 2001, pp. 377-384

Authors: Pechhold, K Patterson, NB Blum, C Fleischacker, CL Boehm, BO Harlan, DM
Citation: K. Pechhold et al., Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent, J IMMUNOL, 166(4), 2001, pp. 2531-2539

Authors: Kirk, AD Harlan, DM
Citation: Ad. Kirk et Dm. Harlan, Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand - Reply, NAT MED, 6(2), 2000, pp. 114-114

Authors: Tadaki, DK Craighead, N Saini, A Celniker, A Burkly, LC Lee, KP Chute, JP Harlan, DM Kirk, AD
Citation: Dk. Tadaki et al., Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity, TRANSPLANT, 70(1), 2000, pp. 162-167

Authors: Herrera, PL Harlan, DM Vassalli, P
Citation: Pl. Herrera et al., A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: Possible role of membrane TNF, P NAS US, 97(1), 2000, pp. 279-284

Authors: Blair, PJ Riley, JL Harlan, DM Abe, R Tadaki, DK Hoffmann, SC White, L Francomano, T Perfetto, SJ Kirk, AD June, CH
Citation: Pj. Blair et al., CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis, J EXP MED, 191(4), 2000, pp. 651-660

Authors: Kirk, AD Burkly, LC Batty, DS Baumgartner, RE Berning, JD Buchanan, K Fechner, JH Germond, RL Kampen, RL Patterson, NB Swanson, SJ Tadaki, DK TenHoor, CN White, L Knechtle, SJ Harlan, DM
Citation: Ad. Kirk et al., Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates, NAT MED, 5(6), 1999, pp. 686-693

Authors: Harlan, DM Kirk, AD
Citation: Dm. Harlan et Ad. Kirk, The future of organ and tissue transplantation - Can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection?, J AM MED A, 282(11), 1999, pp. 1076-1082

Authors: Knechtle, SJ Kirk, AD Fechner, JH Hong, X Dong, Y Hamawy, MM Harlan, DM
Citation: Sj. Knechtle et al., Inducing unresponsiveness by the use of anti-CD3 immunotoxin, CTLA4-Ig, and anti-CD40 ligand, TRANSPLAN P, 31(3B), 1999, pp. 27S-28S

Authors: Kenyon, NS Chatzipetrou, M Masetti, M Ranuncoli, A Oliveira, M Wagner, JL Kirk, AD Harlan, DM Burkly, LC Ricordi, C
Citation: Ns. Kenyon et al., Long-term survival and function of intrahepatic islet allografts in rhesusmonkeys treated with humanized anti-CD154, P NAS US, 96(14), 1999, pp. 8132-8137

Authors: St Louis, DC Woodcock, JB Fransozo, G Blair, PJ Carlson, LM Murillo, M Wells, MR Williams, AJ Smoot, DS Kaushal, S Grimes, JL Harlan, DM Chute, JP June, CH Siebenlist, U Lee, KP
Citation: Dc. St Louis et al., Evidence for distinct intracellular signaling pathways in CD34(+) progenitor to dendritic cell differentiation from a human cell line model, J IMMUNOL, 162(6), 1999, pp. 3237-3248

Authors: Saha, B Saini, A Germond, R Perrin, PJ Harlan, DM Davis, TA
Citation: B. Saha et al., Susceptibility or resistance to Leishmania infection is dictated by the macrophages evolved under the influence of IL-3 or GM-CSF, EUR J IMMUN, 29(7), 1999, pp. 2319-2329

Authors: Kenyon, NS Fernandez, LA Lehmann, R Masetti, M Ranuncoli, A Chatzipetrou, M Iaria, G Han, DM Wagner, JL Ruiz, P Berho, M Inverardi, L Alejandro, R Mintz, DH Kirk, AD Harlan, DM Burkly, LC Ricordi, C
Citation: Ns. Kenyon et al., Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154, DIABETES, 48(7), 1999, pp. 1473-1481

Authors: Saha, B Chattopadhyay, S Germond, R Harlan, DM Perrin, PJ
Citation: B. Saha et al., CTLA4 (CD152) modulates the Th subset response and alters the course of experimental Leishmania major infection, EUR J IMMUN, 28(12), 1998, pp. 4213-4220
Risultati: 1-20 |